Navigation Links
Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
Date:4/1/2008

Leading Expert Discusses Study During Late-Breaking Presentations at ACC

CHICAGO, April 1, 2008 /PRNewswire-FirstCall/ -- Bioheart, Inc. (Nasdaq: BHRT) announced today that final six-month, follow-up patient data was presented today during the late-breaking clinical trial sessions at the American College of Cardiology, suggesting that MyoCell(R) myoblast clinical cell therapy is a safe and potentially effective alternative treatment to standard medical therapy alone for improving heart function among patients with previously implanted cardiac devices who are experiencing congestive heart failure.

The findings from the SEISMIC(1) Trial, a 40-patient, randomized, multicenter, controlled, Phase II-a study conducted in Europe, evaluated MyoCell myoblast clinical cell therapy delivered via the MyoCath(R), endoventricular needle-injection catheter in patients previously fitted with implanted cardiac defibrillators(ICDs), receiving standard medical therapy and who are experiencing congestive heart failure. On admission to the trial, patients were randomized on a two-to-one ratio into the treatment versus control groups with 26 patients receiving MyoCell therapy and 14 patients in the control group. All patients were experiencing congestive heart failure and were previously fitted with ICDs and receiving standard medical therapy. Both the MyoCell biologic therapy and the MyoCath needle-injection catheter, developed by Bioheart, Inc., are currently being studied as investigational products.

"The results from the SEISMIC Trial are encouraging," said Prof. Patrick W. Serruys, MD, PhD, Principal Investigator and Chief, Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center - Rotterdam, the Netherlands. "While
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
2. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
3. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
4. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
5. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
6. Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital
7. TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
8. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
9. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
10. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
11. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... PARK, Calif., Nov. 25 Praxis Elec...gs in the American Academy of Family Physicians, (...er Satisfaction Survey for improving medical quali...l critical for new ARRA Stimulus legislation. Prax...MR had a positive effect in determining their sala...
(Date:11/25/2009)...LADELPHIA, Nov. 25 ERT (...J. McKelvey, the Company,s President and CEO, and ...ent and CFO, are scheduled to present at the 21st ...0 PM EST on December 1, 2009 in New York City, New...sentation by visiting the Company,s corporate webs...
(Date:11/25/2009)...E PARK, Md., Nov. 25 Re...having cream-like foam that stops severe bleeding,... Security Idea category of the Global Security Cha..., Selected from more than 100 entries from around...n at the GSC Security Summit conference held at th...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3In Memory of Patrick Swayze Songwriter Encourages People to Throw Away Cigarettes and Shell Give You Her New CD Free 21 61801 1CVS pharmacy Kicks Off Annual Thanks and Giving 28R 29 Campaign for the St Jude Childrens Research Hospital 61798 1CVS pharmacy Kicks Off Annual Thanks and Giving 28R 29 Campaign for the St Jude Childrens Research Hospital 61798 2Health Care Reform 3A Communicating Policy With Hispanic Media 61795 1Health Care Reform 3A Communicating Policy With Hispanic Media 61795 2Health Care Reform 3A Communicating Policy With Hispanic Media 61795 3
...W, Calif., March 6 Concentric Medical,Inc., the g...ic stroke,patients, today announced that the resul...he April 2008 edition of the medical journal, Stro...dying safety and efficacy of the,Merci Retrieval S...ered,into the brain and is designed to restore blo...
... Miami Breast Cancer Conference, study demonstrate... effective., NEWPORT NEWS, Va., March 6 A recent...r of Breast Imaging at Solis Bertrand Breast,Cente...ignificant value of,Breast-Specific Gamma Imaging ...stics; specifically demonstrating BSGI to be a use...
Other Medicine Technology:Multi Merci Trial Results Published in Peer Reviewed Journal 2Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 2Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics 3
(Date:11/26/2009)...m of the Live Life Again Center, a practice offeri...owing number of physicians who are taking advanta...ith individuals who are interested in surgical wei...m is utilizing Facebook to share before-and-after ... community. , Dallas, TX ...
(Date:11/26/2009)...nications announces a highly effective and unconve...gling to make an economic recovery. , ...s is the type of challenge that could send ailing ...Dr. David Benton, business growth expert and autho...ash; The Rfactor Intensive . “Fear is one...
(Date:11/25/2009)...ewswire-USNewswire/ -- When most people hear the a...iropractor can also give patients the help they ne...which is where your jaw (mandible) contacts/connec...t common symptoms associated with TMJ dysfunction ...jaw. But many other symptoms can be caused from T...
(Date:11/25/2009)... 25 Onyx Pharmaceutica... company will host two investor events in December... - 9:00 a.m. CT/10:00 a.m. ET ,, Principal in...nding carfilzomib in relapsed and/or refractory mu...ociety of Hematology (ASH) Annual Meeting and Expo...
(Date:11/25/2009)...re/ - Sentinelle Medical Inc., a leading manufactu... software launches a suite of new leading edge cli...g software platform at this year,s Radiological So...icago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hall A)...y images generated by Sentinelle,s specialized MRI...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
.... 12 eDiets.com,Inc. (Nasdaq: DIET ), leveraging...tions to both consumers and businesses, today anno...nced earnings conference call. The,Company will re...ence call and audio webcast the following day, Thu...
...harmaceuticals, CINCINNATI, Nov. 12 Blaine Pharm...rk Rinker to Vice President of Sales. Mark,will be...opment activities,and sales management as well as ...has gained,significant ground as an over-the-count...
...season brings with it an increase in burn-related ...United States, fires and burns result in almost 4,...injuries among all age groups. , A new study cond...dren and adolescents in the U.S. may be a more sig...
...om the University of California San Francisco has ... whether or not a woman is likely to develop subse... a noninvasive form of early breast cancer. The re...ld receive more or less aggressive therapy. , App...
...re-FirstCall/ - Transition Therapeutics Inc.,("Tra...TH) will hold a,conference call on Wednesday, Nove...t Quarter fiscal 2008 financial results. Dr. Tony ...ss release to,be issued prior to the call. In orde...
...n on Health releases nationwide eValue8,findings, ...ue8,(TM) report of health plan performance release...ion on Health (NBCH), health plans could do a,bett...st providers and member health maintenance. Releas...
Other Medicine News:Health News:eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call 2Health News:Mark Rinker Named Vice President of Sales for Blaine Pharmaceuticals 2Health News:Burn injuries take devastating toll on nation's children 2Health News:Biomarkers predict risk for invasive breast cancer years before the tumor develops 2Health News:Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2008 Financial Results on Wednesday, November 14, at 8:30 A.M. EST 2Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 2Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 3Health News:National Survey Finds Employers are Challenging Health Plans to Better Use Resources to Prevent Illness and Improve Patient Safety 4
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: